Health

Covid-19 Drug Duo Achievements: GoldenBiotech's New Drug Antroquinonol (HOCENA) Trial Receives Positive Response from DMC Review and Licenses for 4 Countries

TAIPEI, Feb. 4, 2021 /PRNewswire/ -- Golden Biotechnology Corp.(TPEx:4132)("GoldenBiotech"), a leading Taiwanese biopharmaceutical company, announced that it has made two achievements for its Covid-19 new drug candidate Antroquinonol® (HOCENA®): receiving positive response after DMC review in Ph...

2021-02-04 18:41 2015

Mentice publishes the company's year-end report for the period January-December 2020

STOCKHOLM, Feb. 4, 2021 /PRNewswire/ -- Strong order intake and substantial improvement of the company's order book as well as operating cash flow Fourth quarter (October-December 2020)            * Order intake amounted to 73.1 (54.7) MSEK. * Net sales amounted to 45.9 (60.2) MSEK. * Ope...

2021-02-04 16:08 1512

Asia takes more control of health and retirement amid Covid-19 - Manulife survey

* Manulife survey reveals healthier, fitter lifestyle habits across Asia * Greater appetite in the region to buy new insurance as digital trends accelerate HONG KONG, Feb. 4, 2021 /PRNewswire/ -- A year on from Covid-19 first entering the public consciousness, people acrossAsia are taking mor...

2021-02-04 13:00 4195

Vemlidy(r) Demonstrates Continued Efficacy and Improved Safety for Asian Patients with Hepatitis B

SINGAPORE, Feb. 4, 2021 /PRNewswire/ -- Gilead Sciences announced today at the 2021 Asian Pacific Association for the Study of the Liver Conference (APASL), findings from two sub-analyses that demonstrated the continued efficacy and improved safety of Vemlidy® (tenofovir alafenamide 25 mg, TAF) ...

2021-02-04 12:00 4574

Cigna Hong Kong and The CareVoice Partner to Roll Out Bluum Woman

HONG KONG, Feb. 4, 2021 /PRNewswire/ -- Cigna's (NYSE: CI) Hong Kong business today announced a new partnership with The CareVoice, a leading Asian health insurtech company. The partnership will see the launch of "blüüm woman", a solution that provides flexible medical protection and innovative d...

2021-02-04 11:00 3176

Protect the Family with The World's First Intelligent CIO2 Air Purifier

Singapore, Feb. 4, 2021 /PRNewswire/ -- Mamoru Marketing, the exclusive distributor of Ecom products inSingapore, is introducing a new product to protect families in 2021. The big brother of the EA Mask, the Ecom Mask 030 Plus Disinfection Air Purifier has 10 unique features that differentiate it...

2021-02-04 10:19 1985

NCCN Gets Personal About Improving Global Cancer Care for World Cancer Day

Nonprofit alliance behind gold standard oncology guidelines shares stories of personal connections to cancer that inspire many within the organization. Global oncology community looks at the impact from COVID-19 on cancer care over the past year. PLYMOUTH MEETING, Pa., Feb. 4, 2021 /PRNewswire/ ...

2021-02-04 08:05 3173

Edogawa Hospital in Tokyo Installs Japan's First ViewRay MRIdian® Linac

CLEVELAND, Feb. 4, 2021 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that Edogawa Hospital in Tokyo is the first hospital inJapan to treat patients with the MRIdian Linac System. Edogawa Hospital began treating patients in 2018 on the MRIdian cobalt system. The upgrade to MRIdi...

2021-02-04 07:43 7433

FDA Approves TEPMETKO® as the First and Only Once-daily Oral MET Inhibitor for Patients with Metastatic NSCLC with METex14 Skipping Alterations

Not intended for distribution in the USA, Canada or UK - TEPMETKO is approved for both treatment naïve and previously treated MET ex14 positive NSCLC patients - TEPMETKO demonstrated consistent and durable responses in both treatment naïve and previously treatedMETex14 patients in the VISION stud...

2021-02-04 02:57 1619

Eucure Biopharma Announces Encouraging Antitumor Activity of Its anti-CD40 Antibody in PD-1 Refractory Ocular Melanoma when Combined with Junshi Biosciences' Toripalimab

BOSTON and BEIJING, Feb. 3, 2021 /PRNewswire/ -- Eucure Biopharma, a biopharmaceutical company dedicated to developing immuno-oncology antibody drugs, announced that its investigational anti-CD40 antibody drug (YH003), when combined with Junshi Biosciences' anti-PD-1 antibody Toripalimab (TUOYI®)...

2021-02-03 23:45 5407

Longevity Acquisition Corporation Announces 4D pharma Update on Oncology Program

NEW YORK, Feb. 3, 2021 /PRNewswire/ -- Longevity Acquisition Corporation (NASDAQ: LOAC) (the "Company"), a publicly-traded special purpose acquisition company, announced today that onFebruary 3, 2021, 4D pharma plc (AIM: DDDD) ("4D pharma"), a pharmaceutical company leading the development of Liv...

2021-02-03 22:00 6634

More Patients Set to Benefit as Kanghong Pharmaceutical Targets New Indications with Conbercept

CHENGDU, China, Feb. 3, 2021 /PRNewswire/ -- Chengdu Kanghong Pharmaceutical Group ("Kanghong", SHE: 002773), has received Special Protocol Assessments from the Food and Drug Administration for three new indications for its biologic drug conbercept. The drug is an anti-VEGF fusion protein, approv...

2021-02-03 22:00 4324

Guardant360 CDx submitted for regulatory approval in Japan

TOKYO, Feb. 3, 2021 /PRNewswire/ -- Guardant Health Japan, an affiliate of Guardant Health Asia,Middle East & Africa (AMEA) has announced that it has submitted its application to the Ministry of Health, Labour and Welfare (MHLW) for regulatory approval of Guardant360 CDx, a liquid biopsy test for...

2021-02-03 18:41 2826

Innovent and Lilly Jointly Announce the Approval of TYVYT® (sintilimab injection) by China NMPA in Combination with Pemetrexed and Platinum Chemotherapy as First-Line Therapy for Nonsquamous Non-Small Cell Lung Cancer

SAN FRANCISCO and SUZHOU, China, Feb. 3, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major disease...

2021-02-03 12:30 9264

MBC Broadcasts COVID-19 Special with TVU Networks' Live Contribution Technology

SHANGHAI, Feb. 3, 2021 /PRNewswire/ -- South Korea's Munhwa Broadcasting Corp. (MBC), the nation's second largest broadcaster, relied on three integrated remote production technologies fromTVU Networks , the market and technology leader in cloud and IP-based live vide...

2021-02-03 11:02 1938

Ping An Healthcare and Technology Company Limited posts revenue of RMB 6,866 million in 2020

Launches comprehensive strategic upgrade Revenue from online medical services, its core business, grows 82.4% year-on-year HONG KONG, Feb. 3, 2021 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor"; Stock Code: 01833.HK), a leading internet healthcare se...

2021-02-03 01:03 8223

Elekta's MOSAIQ and Versa HD earn top honors in 2021 Best in KLAS: Software and Services Report

ATLANTA, Feb. 3, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) today announced that itsMOSAIQ® Oncology Information System (OIS) and Versa HD™ linear accelerator have been named "Best in KLAS" in the 2021 Best in KLAS: Software and Services Report. MOSAIQ was ranked first in the Oncology (Radiation) ca...

2021-02-03 00:30 3556

Latest Cigna International Markets Well-being Pulse Study Shows Global Populations Adapting but the COVID-19 Pandemic is Negatively Impacting People's Views of the Future

BLOOMFIELD, Conn., Feb. 2, 2021 /PRNewswire/ -- Cigna's (NYSE:CI) International Markets business has published its fourthCOVID-19 Global Impact Study. This series, which builds on Cigna's annual 360 Well-being Study, provides further insight into the global impact of the COVID-19 pandemic on peop...

2021-02-02 23:00 9078

Dyadic and TurtleTree Scientific enter strategic partnership

SAN FRANCISCO, Feb. 2, 2021 /PRNewswire/ -- Dyadic International, Inc. ("Dyadic") (DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to accelerate development, lower production costs, and improv...

2021-02-02 22:00 1351

China Jo-Jo Drugstores Releases 2020 Letter from the Chairman

HANGZHOU, China, Feb. 2, 2021 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products, and healthcare provider in China, released a letter to sha...

2021-02-02 21:30 4822
1 ... 661662663664665666667 ... 858